Stay updated on Durvalumab Consolidation in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Durvalumab Consolidation in NSCLC Clinical Trial page.

Latest updates to the Durvalumab Consolidation in NSCLC Clinical Trial page
- CheckyesterdayChange DetectedThe revision history now shows a new site revision v3.7.0 and removes the earlier v3.6.6 entry, updating the page's versioning trail. This is a metadata update to the page's history and does not affect the study data or functionality.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedRevision label on the page updates from v3.6.5 to v3.6.6, indicating a new version of the study history page. This change is a metadata update and does not modify the actual study data or user-facing content.SummaryDifference0.1%

- Check36 days agoChange DetectedA dedicated version history section has been added to the study record history page, including labels like Study Record Versions and Record History. The UI now exposes actions such as Save and Download, and shows related views (Results Posted, Researcher View) to help users access and compare past submissions.SummaryDifference41%

- Check43 days agoChange DetectedNew version 54 dated 2026-08-06 introduces an updated Study Status and Revision: v3.6.5; the previous v3.6.4 entry from 2026-05-13 is removed from the history.SummaryDifference0.3%

- Check58 days agoChange DetectedThe page shows a revision update from v3.6.3 to v3.6.4, indicating a new version of the page. This update reflects an underlying software revision rather than a change to the study details displayed.SummaryDifference0.1%

- Check79 days agoChange DetectedA new revision entry v3.6.3 was added to the record history, superseding the previous v3.6.2 and signaling an updated version of the study record.SummaryDifference0.1%

Stay in the know with updates to Durvalumab Consolidation in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab Consolidation in NSCLC Clinical Trial page.